Key result
Postoperative StepWatch activity best discriminates hospital outcomes including 30-day readmission.
Why the study?
Comparative data for different activity monitoring approaches after cardiac surgery, their predictive ability over clinical characteristics, and specific activity thresholds were lacking.
Do wearable accelerometers provide additive value in early postoperative risk-stratification for hospital-based outcomes in cardiac surgery patients?
Cohort (n=193)
Do wearable accelerometers provide additive value in early postoperative risk-stratification for hospital-based outcomes in cardiac surgery patients?
Effect estimate: C-statistic 0.71-0.76
Wearable accelerometers, particularly the StepWatch monitor, provide additive value in early postoperative risk-stratification for hospital-based outcomes after cardiac surgery.
Activity monitor data may enhance post-cardiac surgery risk stratification beyond clinical factors; leaves open optimal thresholds and prospective outcome impact.
Objective: Wearable activity monitors can provide detailed data on activity after cardiac surgery and discriminate a patient's risk for hospital-based outcomes. However, comparative data for different monitoring approaches, as well as predictive ability over clinical characteristics, are lacking. In addition, data on specific thresholds of activity are needed. The objective of this study was to compare 3 wearable activity monitors and 1 observational mobility scale in discriminating risk for 3 hospital-based outcomes, and to establish clinically relevant step thresholds. Methods: Cardiac surgery patients were enrolled between June 2016 and August 2017 in a cohort study. Postoperative activity was measured by 3 accelerometry monitors (StepWatch Ambulation Monitor, Fitbit Charge HR, and ActiGraph GT9X) and 1 nurse-based observation scale. Monitors represent a spectrum of characteristics, including wear location (ankle/wrist), output (activity counts/steps), consumer accessibility, and cost. Primary outcomes were duration of hospitalization >7 days, discharge to a nonhome location, and 30-day readmission. Results: Data were available from 193 patients (median age 67 years [interquartile range, 58-72]). All postoperative day 2 activity metrics (ie, from StepWatch, Fitbit, ActiGraph, and the observation scale) were independently associated with prolonged hospitalization and discharge to a nonhome location. Only steps as measured by StepWatch was independently associated with 30-day readmission. Overall, StepWatch provided the greatest discrimination (C-statistics 0.71-0.76 for all outcomes). Step thresholds between 250 and 500 steps/day identified between 74% and 96% of patients with any primary outcome. Conclusions: Data from wearable accelerometers provide additive value in early postoperative risk-stratification for hospital-based outcomes. These results both support and provide guidance for activity-monitoring programs after cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2022) conducted a cohort in Cardiac surgery (n=193). Wearable accelerometers (StepWatch, Fitbit, ActiGraph) vs. Nurse-based observation scale was evaluated on Duration of hospitalization >7 days, discharge to a nonhome location, and 30-day readmission (C-statistic 0.71-0.76). Postoperative activity measured by the StepWatch monitor provided the greatest discrimination for hospital-based outcomes, including 30-day readmission (C-statistics 0.71-0.76).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: